Works about TREATMENT of helicobacter pylori infections
Results: 768
RE: Effects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
RE: Effects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Effects of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality in Subgroups.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju116
- By:
- Publication type:
- Article
Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2016, v. 31, p. 46, doi. 10.1080/14756366.2016.1186023
- By:
- Publication type:
- Article
Urease activity and l-ascorbic acid.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 3, p. 309, doi. 10.3109/14756366.2010.504675
- By:
- Publication type:
- Article
Efficacy of 1-week ranitidine-bismuth-citrate (RBC)-based triple therapy for eradication of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 9, p. 1251, doi. 10.1046/j.1365-2036.1999.0612a.x
- By:
- Publication type:
- Article
5-Day H. pylori eradication.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 9, p. 1252, doi. 10.1046/j.1365-2036.1999.0612c.x
- By:
- Publication type:
- Article
5-Day H. pylori eradication.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 9, p. 1253, doi. 10.1046/j.1365-2036.1999.0612d.x
- By:
- Publication type:
- Article
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 8, p. 1047, doi. 10.1046/j.1365-2036.1999.00555.x
- By:
- Publication type:
- Article
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 8, p. 1071, doi. 10.1046/j.1365-2036.1999.00572.x
- By:
- Publication type:
- Article
Helicobacter pylori and gastro-oesophageal reflux disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 8, p. 1133, doi. 10.1046/j.1365-2036.1999.0561d.x
- By:
- Publication type:
- Article
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 8, p. 1063, doi. 10.1046/j.1365-2036.1999.00563.x
- By:
- Publication type:
- Article
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 8, p. 1079, doi. 10.1046/j.1365-2036.1999.00580.x
- By:
- Publication type:
- Article
Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta-analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 7, p. 857, doi. 10.1046/j.1365-2036.1999.00542.x
- By:
- Publication type:
- Article
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection—comparison with omeprazole and lansoprazole.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 6, p. 741, doi. 10.1046/j.1365-2036.1999.00526.x
- By:
- Publication type:
- Article
A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 6, p. 769, doi. 10.1046/j.1365-2036.1999.00551.x
- By:
- Publication type:
- Article
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 6, p. 781, doi. 10.1046/j.1365-2036.1999.00552.x
- By:
- Publication type:
- Article
Prospective evaluation of ranitidine bismuth citrate-based triple therapy for the treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 5, p. 661, doi. 10.1046/j.1365-2036.1999.00509.x
- By:
- Publication type:
- Article
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 5, p. 637, doi. 10.1046/j.1365-2036.1999.00513.x
- By:
- Publication type:
- Article
Spiramycin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 5, p. 651, doi. 10.1046/j.1365-2036.1999.00517.x
- By:
- Publication type:
- Article
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 5, p. 643, doi. 10.1046/j.1365-2036.1999.00522.x
- By:
- Publication type:
- Article
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 4, p. 497, doi. 10.1046/j.1365-2036.1999.00493.x
- By:
- Publication type:
- Article
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 4, p. 503, doi. 10.1046/j.1365-2036.1999.00498.x
- By:
- Publication type:
- Article
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 4, p. 489, doi. 10.1046/j.1365-2036.1999.00504.x
- By:
- Publication type:
- Article
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 4, p. 483, doi. 10.1046/j.1365-2036.1999.00510.x
- By:
- Publication type:
- Article
Clarithromycin-based triple therapies.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 3, p. 437, doi. 10.1046/j.1365-2036.1999.0467a.x
- By:
- Publication type:
- Article
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 3, p. 303, doi. 10.1046/j.1365-2036.1999.00477.x
- By:
- Publication type:
- Article
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 3, p. 317, doi. 10.1046/j.1365-2036.1999.00492.x
- By:
- Publication type:
- Article
Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1999, v. 13, n. 1, p. 27, doi. 10.1046/j.1365-2036.1999.00440.x
- By:
- Publication type:
- Article
Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 12, p. 1263, doi. 10.1046/j.1365-2036.1998.00422.x
- By:
- Publication type:
- Article
Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 12, p. 1269, doi. 10.1046/j.1365-2036.1998.00430.x
- By:
- Publication type:
- Article
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 11, p. 1113, doi. 10.1046/j.1365-2036.1998.00413.x
- By:
- Publication type:
- Article
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 10, p. 997, doi. 10.1046/j.1365-2036.1998.00392.x
- By:
- Publication type:
- Article
H[sub 2]-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 9, p. 873, doi. 10.1046/j.1365-2036.1998.00391.x
- By:
- Publication type:
- Article
Low rate of emergence of clarithromycin-resistant Helicobacter pylori with amoxycillin co-therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 9, p. 887, doi. 10.1046/j.1365-2036.1998.00378.x
- By:
- Publication type:
- Article
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 9, p. 881, doi. 10.1046/j.1365-2036.1998.00382.x
- By:
- Publication type:
- Article
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 8, p. 741, doi. 10.1046/j.1365-2036.1998.00362.x
- By:
- Publication type:
- Article
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 8, p. 725, doi. 10.1046/j.1365-2036.1998.00367.x
- By:
- Publication type:
- Article
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 8, p. 735, doi. 10.1046/j.1365-2036.1998.00370.x
- By:
- Publication type:
- Article
Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 7, p. 635, doi. 10.1046/j.1365-2036.1998.00350.x
- By:
- Publication type:
- Article
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 7, p. 613, doi. 10.1046/j.1365-2036.1998.00354.x
- By:
- Publication type:
- Article
Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 6, p. 527, doi. 10.1046/j.1365-2036.1998.00326.x
- By:
- Publication type:
- Article
Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 6, p. 563, doi. 10.1046/j.1365-2036.1998.00335.x
- By:
- Publication type:
- Article
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 5, p. 433, doi. 10.1046/j.1365-2036.1998.00319.x
- By:
- Publication type:
- Article
Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 5, p. 457, doi. 10.1046/j.1365-2036.1998.00324.x
- By:
- Publication type:
- Article
Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 5, p. 439, doi. 10.1046/j.1365-2036.1998.00330.x
- By:
- Publication type:
- Article
Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 5, p. 453, doi. 10.1046/j.1365-2036.1998.00332.x
- By:
- Publication type:
- Article
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 5, p. 447, doi. 10.1046/j.1365-2036.1998.00334.x
- By:
- Publication type:
- Article
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 3, p. 273, doi. 10.1046/j.1365-2036.1998.00290.x
- By:
- Publication type:
- Article
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 3, p. 277, doi. 10.1046/j.1365-2036.1998.00296.x
- By:
- Publication type:
- Article